Dose-dense chemotherapy: A possible high cost-effectiveness treatment for ovarian cancer

Taiwan J Obstet Gynecol. 2020 May;59(3):351-352. doi: 10.1016/j.tjog.2020.03.001.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / economics
  • Carboplatin / administration & dosage
  • Carboplatin / adverse effects
  • Carcinoma, Ovarian Epithelial / drug therapy*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy*
  • Paclitaxel / administration & dosage
  • Paclitaxel / adverse effects

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Paclitaxel